All In Biotech

Free tool

FAERS Monitor: Claritin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021952 or its brand name (Claritin, Loratadine). Reports on generic versions are filed under their own applications.

Reports

103,057

Serious

49,212

48% of reports

Hospitalization

22,956

Death reported

4,538

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective11,854
  • fatigue6,591
  • nausea5,790
  • headache5,304
  • dyspnoea4,791
  • diarrhoea4,780
  • off label use4,567
  • dizziness4,289
  • pain4,055
  • rash3,368
  • pruritus3,350
  • cough3,083
  • vomiting2,949
  • arthralgia2,893
  • somnolence2,821

Reports by year received

View as table
YearReports
2004965
20051,071
20061,067
2007939
20081,073
20091,316
20101,637
20112,020
20123,015
20133,959
20144,683
20157,017
20168,555
20178,774
20187,746
20197,819
20207,024
20216,285
20226,083
20235,477
20245,990
20255,930
20264,611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,951,102 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
somnolenceSignal2,8212.92.83,459
coughSignal3,0832.32.22,163
drug ineffective11,8541.81.84,834
pruritus3,3501.81.71,169
dizziness4,2891.81.71,433
fatigue6,5911.71.72,108
dyspnoea4,7911.71.71,514
headache5,3041.71.71,679
rash3,3681.61.5729
diarrhoea4,7801.51.5857
nausea5,7901.51.5984
arthralgia2,8931.41.4368
pain4,0551.31.3375
vomiting2,9491.31.2185
off label use4,5671.11.019

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.